BCL2 and B-cell chronic lymphocytic leukemia: This strategy was effective to kill Bcl-2-dependent cell models, including primary CLL cells18, DLBCL cell models19, small cell lung cancer (SCLC) cells20, and multiple myeloma and follicular lymphoma21.